Monopar Therapeutics MNPR Cash Flow Statement (2017-2026)

NASDAQ MNPR
$117.99 -0.56 (-0.47%)
As of: Sep 4, 2026 · 3:58 PM EDT
Reported Financials

Monopar Therapeutics Quarterly Cash Flow Statement

Periods 37 quarters
Latest Jun 2026

Monopar Therapeutics cash flow statement data for the quarter ended Jun 2026. This cash flow statement covers 37 quarters of results from Mar 2017 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow Statement Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Jun2026
Operating Activities
Net Income
-2.09M-2.46M-2.68M-2.46M-2.76M-2.41M-14.04M-2.49M-2.35M-1.95M-15.51M-1.64M-1.72M-1.48M-2.62M-2.45M-3.44M-5.35M
Share-based CompensationStock Comp.
1.54M1.64M0.35M2.07M1.88M1.62M0.39M2.15M2.11M2.11M0.47M2.12M2.10M0.43M3.69M9.80M0.96M0.81M1.10M16.40M
Cash from OperationsCash from Ops.
-1.41M-1.94M-2.03M-2.47M-1.31M-2.15M-1.30M-2.27M-2.10M-1.94M-1.55M-1.66M-1.68M-1.07M-2.00M-5.66M-1.08M-2.09M-3.37M
Change in Working Capital
Change in Accured ExpensesChange Accured Exp.
0.30M0.14M0.34M-0.53M1.09M-0.28M1.20M-0.25M-0.37M-0.50M-0.21M-0.31M-0.35M0.03M1.14M-0.77M0.07M0.36M0.74M
Other Working Capital ChangesOther WC Changes
-0.02M-0.08M-0.04M0.02M-0.05M-0.13M-0.01M0.06M0.00M-0.04M-0.01M0.04M-0.05M-0.00M0.03M0.62M-0.25M0.32M-0.71M
Investing Activities
Acquisitions
Change in Acquisitions & DivestmentsChange Acquisitions
1.98M4.92M2.96M2.96M0.99M1.60M2.40M3.60M16.10M
Cash from Investing ActivitiesCash from Investing
-4.92M-0.98M2.95M-0.01M2.97M-0.98M-0.00M0.99M-14.34M-0.33M1.19M-2.13M-62.19M
Financing Activities
Other financing activitiesOther financing
41.00128.001.69M-1.69M84.000.02M0.00M214.000.54M
Cash from Financing ActivitiesCash from Financing
-0.02M-0.01M-0.01M-0.02M-0.07M-0.02M0.14M0.80M0.64M0.25M0.33M3.18M-0.01M-0.02M56.14M-0.12M-0.32M92.39M-0.38M
Change in Capital Stock
Net Shares Issued and RepurchasedNet Shares Issued
0.40M0.55M0.60M0.51M0.10M0.01M0.04M0.22M0.30M
Net Equity Issued and RepurchasedNet Equity Issued
0.11M0.82M0.66M0.25M0.34M3.19M-1.001.01M
Additional items
Exchange Rate EffectFX Effect
-140.008.000.00M-659.000.02M0.03M-0.05M-0.01M-0.00M0.01M-0.01M-0.00M0.00M0.00M-0.00M-54.00-0.00M376.000.10M
Change in Cash
-1.43M-1.95M-2.04M-2.48M-1.36M-2.15M-6.13M-2.46M1.49M-1.70M1.75M0.54M-1.69M-0.10M39.80M-6.10M-0.21M88.18M-65.84M
Free Cash FlowFCF
-1.41M-1.94M-2.03M-2.47M-1.31M-2.15M-1.30M-2.27M-2.10M-1.94M-1.55M-1.66M-1.68M-1.07M-2.00M-5.66M-1.08M-2.09M-3.37M
Net Cash FlowNCF
-1.43M-1.95M-2.04M-2.48M-1.38M-2.17M-6.08M-2.45M1.49M-1.71M1.76M0.54M-1.69M-0.10M39.80M-6.10M-0.21M88.18M-65.94M